Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/27/2026 | Q4 | $135.6M | -- | -- | $0.42 | -- |
| 10/28/2025 | Q3 | $136.3M | $187.2M | $0.39 | $0.41 | -$0.02 |
| 07/29/2025 | Q2 | $126.5M | $184.3M | $0.32 | $0.35 | -$0.03 |
| 04/29/2025 | Q1 | $117.6M | $170.1M | $0.32 | $0.32 | -$0.00 |
| 01/28/2025 | Q4 | $119.9M | $175.3M | $0.35 | $0.35 | $0.00 |
| 10/29/2024 | Q3 | $119.5M | $178.8M | $0.31 | $0.36 | -$0.04 |
| 07/23/2024 | Q2 | $118M | $175.7M | $0.36 | $0.35 | $0.01 |
| 04/23/2024 | Q1 | $120M | $169M | $0.37 | $0.36 | $0.01 |
| 01/30/2024 | Q4 | $123.7M | $167.3M | $0.44 | $0.39 | $0.05 |
| 10/24/2023 | Q3 | -- | $165.7M | $0.38 | -- | -- |
| 07/25/2023 | Q2 | -- | $155.8M | $0.42 | -- | -- |
| 04/25/2023 | Q1 | -- | $137.3M | $0.30 | -- | -- |
| 01/24/2023 | Q4 | -- | $120.5M | $0.38 | -- | -- |
| 10/25/2022 | Q3 | -- | $112.5M | $0.36 | -- | -- |
| 07/26/2022 | Q2 | -- | $100.9M | $0.33 | -- | -- |
| 04/27/2022 | Q1 | -- | $96.6M | $0.29 | -- | -- |
| 01/25/2022 | Q4 | -- | $96.8M | $0.37 | -- | -- |
| 10/26/2021 | Q3 | -- | $101.7M | $0.36 | -- | -- |
| 07/27/2021 | Q2 | -- | $97.8M | $0.31 | -- | -- |
| 04/27/2021 | Q1 | -- | $100.7M | $0.41 | -- | -- |
| 01/26/2021 | Q4 | -- | $100.4M | $0.27 | -- | -- |
| 10/27/2020 | Q3 | -- | $100.5M | $0.20 | -- | -- |
| 07/28/2020 | Q2 | -- | $95.6M | $0.24 | -- | -- |
| 04/28/2020 | Q1 | -- | $100.7M | $0.05 | -- | -- |
| 01/28/2020 | Q4 | -- | $104.2M | $0.27 | -- | -- |
| 10/29/2019 | Q3 | -- | $104.6M | $0.27 | -- | -- |
| 07/23/2019 | Q2 | -- | $104M | $0.28 | -- | -- |
| 04/23/2019 | Q1 | -- | $99M | $0.25 | -- | -- |
| 01/29/2019 | Q4 | -- | $98.5M | $0.27 | -- | -- |
| 10/23/2018 | Q3 | -- | $94.6M | $0.25 | -- | -- |
| 07/24/2018 | Q2 | -- | $99.2M | $0.32 | -- | -- |
| 04/24/2018 | Q1 | -- | $87.8M | $0.24 | -- | -- |
| 01/23/2018 | Q4 | -- | $91M | $0.04 | -- | -- |
| 10/25/2017 | Q3 | -- | $85.2M | $0.22 | -- | -- |
| 07/26/2017 | Q2 | -- | $82.1M | $0.14 | -- | -- |
| 04/25/2017 | Q1 | -- | $73.1M | $0.18 | -- | -- |
| 01/25/2017 | Q4 | -- | $72.6M | $0.20 | -- | -- |
| 10/26/2016 | Q3 | -- | $71M | $0.19 | -- | -- |
| 07/27/2016 | Q2 | -- | $69.9M | $0.14 | -- | -- |
| 04/26/2016 | Q1 | -- | $68.1M | $0.14 | -- | -- |
| 01/27/2016 | Q4 | -- | $66.8M | $0.11 | -- | -- |
First Commonwealth Financial Corp. (Pennsylvania) reported $187.2M worth of top line sales in its most recent quarter.
First Commonwealth Financial Corp. (Pennsylvania) announced earnings per share of $0.39 which represents a miss of analyst forecast a $0.41 per share.
First Commonwealth Financial Corp. (Pennsylvania) reported -- that represents -- per share over the last quarter.
First Commonwealth Financial Corp. (Pennsylvania)'s earnings are forecast to grow from $1.40 per share to $1.40 per share next year representing an increase of 8.36%.
First Commonwealth Financial Corp. (Pennsylvania)'s next earnings date is January 27, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.